Cargando…

Feasibility and clinical usefulness of modelling glioblastoma migration in adjuvant radiotherapy

Glioblastoma (GBM) is one of the most common primary brain tumours in adults, with a dismal prognosis despite aggressive multimodality treatment by a combination of surgery and adjuvant radiochemotherapy. A detailed knowledge of the spreading of glioma cells in the brain might allow for more targete...

Descripción completa

Detalles Bibliográficos
Autores principales: Knobe, Sven, Dzierma, Yvonne, Wenske, Michael, Berdel, Christian, Fleckenstein, Jochen, Melchior, Patrick, Palm, Jan, Nuesken, Frank G., Hunt, Alexander, Engwer, Christian, Surulescu, Christina, Yilmaz, Umut, Reith, Wolfgang, Rübe, Christian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9948823/
https://www.ncbi.nlm.nih.gov/pubmed/33966944
http://dx.doi.org/10.1016/j.zemedi.2021.03.004
_version_ 1784892859974942720
author Knobe, Sven
Dzierma, Yvonne
Wenske, Michael
Berdel, Christian
Fleckenstein, Jochen
Melchior, Patrick
Palm, Jan
Nuesken, Frank G.
Hunt, Alexander
Engwer, Christian
Surulescu, Christina
Yilmaz, Umut
Reith, Wolfgang
Rübe, Christian
author_facet Knobe, Sven
Dzierma, Yvonne
Wenske, Michael
Berdel, Christian
Fleckenstein, Jochen
Melchior, Patrick
Palm, Jan
Nuesken, Frank G.
Hunt, Alexander
Engwer, Christian
Surulescu, Christina
Yilmaz, Umut
Reith, Wolfgang
Rübe, Christian
author_sort Knobe, Sven
collection PubMed
description Glioblastoma (GBM) is one of the most common primary brain tumours in adults, with a dismal prognosis despite aggressive multimodality treatment by a combination of surgery and adjuvant radiochemotherapy. A detailed knowledge of the spreading of glioma cells in the brain might allow for more targeted escalated radiotherapy, aiming to reduce locoregional relapse. Recent years have seen the development of a large variety of mathematical modelling approaches to predict glioma migration. The aim of this study is hence to evaluate the clinical applicability of a detailed micro- and meso-scale mathematical model in radiotherapy. First and foremost, a clinical workflow is established, in which the tumour is automatically segmented as input data and then followed in time mathematically based on the diffusion tensor imaging data. The influence of several free model parameters is individually evaluated, then the full model is retrospectively validated for a collective of 3 GBM patients treated at our institution by varying the most important model parameters to achieve optimum agreement with the tumour development during follow-up. Agreement of the model predictions with the real tumour growth as defined by manual contouring based on the follow-up MRI images is analyzed using the dice coefficient. The tumour evolution over 103-212 days follow-up could be predicted by the model with a dice coefficient better than 60% for all three patients. In all cases, the final tumour volume was overestimated by the model by a factor between 1.05 and 1.47. To evaluate the quality of the agreement between the model predictions and the ground truth, we must keep in mind that our gold standard relies on a single observer's (CB) manually-delineated tumour contours. We therefore decided to add a short validation of the stability and reliability of these contours by an inter-observer analysis including three other experienced radiation oncologists from our department. In total, a dice coefficient between 63% and 89% is achieved between the four different observers. Compared with this value, the model predictions (62-66%) perform reasonably well, given the fact that these tumour volumes were created based on the pre-operative segmentation and DTI.
format Online
Article
Text
id pubmed-9948823
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-99488232023-02-23 Feasibility and clinical usefulness of modelling glioblastoma migration in adjuvant radiotherapy Knobe, Sven Dzierma, Yvonne Wenske, Michael Berdel, Christian Fleckenstein, Jochen Melchior, Patrick Palm, Jan Nuesken, Frank G. Hunt, Alexander Engwer, Christian Surulescu, Christina Yilmaz, Umut Reith, Wolfgang Rübe, Christian Z Med Phys Original Article Glioblastoma (GBM) is one of the most common primary brain tumours in adults, with a dismal prognosis despite aggressive multimodality treatment by a combination of surgery and adjuvant radiochemotherapy. A detailed knowledge of the spreading of glioma cells in the brain might allow for more targeted escalated radiotherapy, aiming to reduce locoregional relapse. Recent years have seen the development of a large variety of mathematical modelling approaches to predict glioma migration. The aim of this study is hence to evaluate the clinical applicability of a detailed micro- and meso-scale mathematical model in radiotherapy. First and foremost, a clinical workflow is established, in which the tumour is automatically segmented as input data and then followed in time mathematically based on the diffusion tensor imaging data. The influence of several free model parameters is individually evaluated, then the full model is retrospectively validated for a collective of 3 GBM patients treated at our institution by varying the most important model parameters to achieve optimum agreement with the tumour development during follow-up. Agreement of the model predictions with the real tumour growth as defined by manual contouring based on the follow-up MRI images is analyzed using the dice coefficient. The tumour evolution over 103-212 days follow-up could be predicted by the model with a dice coefficient better than 60% for all three patients. In all cases, the final tumour volume was overestimated by the model by a factor between 1.05 and 1.47. To evaluate the quality of the agreement between the model predictions and the ground truth, we must keep in mind that our gold standard relies on a single observer's (CB) manually-delineated tumour contours. We therefore decided to add a short validation of the stability and reliability of these contours by an inter-observer analysis including three other experienced radiation oncologists from our department. In total, a dice coefficient between 63% and 89% is achieved between the four different observers. Compared with this value, the model predictions (62-66%) perform reasonably well, given the fact that these tumour volumes were created based on the pre-operative segmentation and DTI. Elsevier 2021-05-07 /pmc/articles/PMC9948823/ /pubmed/33966944 http://dx.doi.org/10.1016/j.zemedi.2021.03.004 Text en © 2021 The Author(s). Published by Elsevier GmbH on behalf of DGMP, ÖGMP and SSRMP. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Original Article
Knobe, Sven
Dzierma, Yvonne
Wenske, Michael
Berdel, Christian
Fleckenstein, Jochen
Melchior, Patrick
Palm, Jan
Nuesken, Frank G.
Hunt, Alexander
Engwer, Christian
Surulescu, Christina
Yilmaz, Umut
Reith, Wolfgang
Rübe, Christian
Feasibility and clinical usefulness of modelling glioblastoma migration in adjuvant radiotherapy
title Feasibility and clinical usefulness of modelling glioblastoma migration in adjuvant radiotherapy
title_full Feasibility and clinical usefulness of modelling glioblastoma migration in adjuvant radiotherapy
title_fullStr Feasibility and clinical usefulness of modelling glioblastoma migration in adjuvant radiotherapy
title_full_unstemmed Feasibility and clinical usefulness of modelling glioblastoma migration in adjuvant radiotherapy
title_short Feasibility and clinical usefulness of modelling glioblastoma migration in adjuvant radiotherapy
title_sort feasibility and clinical usefulness of modelling glioblastoma migration in adjuvant radiotherapy
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9948823/
https://www.ncbi.nlm.nih.gov/pubmed/33966944
http://dx.doi.org/10.1016/j.zemedi.2021.03.004
work_keys_str_mv AT knobesven feasibilityandclinicalusefulnessofmodellingglioblastomamigrationinadjuvantradiotherapy
AT dziermayvonne feasibilityandclinicalusefulnessofmodellingglioblastomamigrationinadjuvantradiotherapy
AT wenskemichael feasibilityandclinicalusefulnessofmodellingglioblastomamigrationinadjuvantradiotherapy
AT berdelchristian feasibilityandclinicalusefulnessofmodellingglioblastomamigrationinadjuvantradiotherapy
AT fleckensteinjochen feasibilityandclinicalusefulnessofmodellingglioblastomamigrationinadjuvantradiotherapy
AT melchiorpatrick feasibilityandclinicalusefulnessofmodellingglioblastomamigrationinadjuvantradiotherapy
AT palmjan feasibilityandclinicalusefulnessofmodellingglioblastomamigrationinadjuvantradiotherapy
AT nueskenfrankg feasibilityandclinicalusefulnessofmodellingglioblastomamigrationinadjuvantradiotherapy
AT huntalexander feasibilityandclinicalusefulnessofmodellingglioblastomamigrationinadjuvantradiotherapy
AT engwerchristian feasibilityandclinicalusefulnessofmodellingglioblastomamigrationinadjuvantradiotherapy
AT surulescuchristina feasibilityandclinicalusefulnessofmodellingglioblastomamigrationinadjuvantradiotherapy
AT yilmazumut feasibilityandclinicalusefulnessofmodellingglioblastomamigrationinadjuvantradiotherapy
AT reithwolfgang feasibilityandclinicalusefulnessofmodellingglioblastomamigrationinadjuvantradiotherapy
AT rubechristian feasibilityandclinicalusefulnessofmodellingglioblastomamigrationinadjuvantradiotherapy